HESTER BIOSCIENCES
Back to Balance Sheet
|
HESTER BIOSCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | - | - | ₹0.20 Cr | ₹0.15 Cr | ₹0.15 Cr |
What is the latest Contingent Liabilities ratio of HESTER BIOSCIENCES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | ₹0.20 Cr |
| Mar2022 | ₹0.15 Cr |
| Mar2021 | ₹0.15 Cr |
How is Contingent Liabilities of HESTER BIOSCIENCES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | -100.00 | |
| Mar2023 | ₹0.20 Cr | 33.78 | |
| Mar2022 | ₹0.15 Cr | 0.00 | |
| Mar2021 | ₹0.15 Cr | - | |
Compare Contingent Liabilities of peers of HESTER BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HESTER BIOSCIENCES | ₹1,166.9 Cr | 1.5% | -13% | -8.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹414,713.0 Cr | -1.4% | -3.2% | -0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹156,811.0 Cr | -1.9% | -8.7% | 1.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,052.0 Cr | -3.5% | -6.6% | 30.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,927.0 Cr | -4% | -8.3% | 6.3% | Stock Analytics | |
| CIPLA | ₹96,602.7 Cr | -1.9% | -11.9% | -19% | Stock Analytics | |
HESTER BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HESTER BIOSCIENCES | 1.5% |
-13% |
-8.6% |
| SENSEX | 0.6% |
-11.1% |
-6.2% |
You may also like the below Video Courses